| | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2020 ( Subtotal = $0 ) |
| 2020 | 2018 | APEX BIOMEDICAL COMPANY, LLC | 13568 SE 97TH AVE SUITE 202 | CLACKAMAS | OR | 97015 | CLACKAMAS | USA | Extramural Research Programs in the Neurosciences and Neurological Disorders | 000 | 6 | 11/14/2019 | NON-COMPETING CONTINUATION | $0 |
|
 | Issue Date FY: 2018 ( Subtotal = $455,127 ) |
| 2018 | 2018 | APEX BIOMEDICAL COMPANY, LLC | 13568 SE 97TH AVE SUITE 202 | CLACKAMAS | OR | 97015 | CLACKAMAS | USA | Extramural Research Programs in the Neurosciences and Neurological Disorders | 000 | 6 | 6/15/2018 | NON-COMPETING CONTINUATION | $455,127 |
|
 | Issue Date FY: 2017 ( Subtotal = $810,478 ) |
| 2017 | 2017 | APEX BIOMEDICAL COMPANY, LLC | 13568 SE 97TH AVE SUITE 202 | CLACKAMAS | OR | 97015 | CLACKAMAS | USA | Extramural Research Programs in the Neurosciences and Neurological Disorders | 000 | 5 | 7/17/2017 | NON-COMPETING CONTINUATION | $810,478 |
|
 | Issue Date FY: 2016 ( Subtotal = $617,779 ) |
| 2016 | 2016 | APEX BIOMEDICAL COMPANY LLC | 501 NORTH GRAHAM | PORTLAND | OR | 97227 | MULTNOMAH | USA | Extramural Research Programs in the Neurosciences and Neurological Disorders | 000 | 4 | 8/11/2016 | COMPETING CONTINUATION | $617,779 |
|
|